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The vocal extent measure (VEM) represents a new diagnostic tool to express vocal capacity by quantifying the dynamic
performance and frequency range of voice range profiles (VRPs). For VEM calculation, the VRP area is multiplied by the
quotient of the theoretical perimeter of a circle with equal VRP area and the actual VRP perimeter. Since different diseases affect
voice function to varying degrees, pathology-related influences on the VEM should be investigated more detailed in this
retrospective study, three years after VEM implementation. Data was obtained in a standardized voice assessment comprising
videolaryngostroboscopy, voice handicap index (VHI-9i), and acoustic-aerodynamic analysis with automatic calculation of VEM
and dysphonia severity index (DSI). The complete dataset comprised 1030 subjects, from which 994 adults (376 male, 618
female; 18-86 years) were analyzed more detailed. The VEM differed significantly between pathology subgroups (p < 0:001) and
correlated with the corresponding DSI values. Regarding VHI-9i, the VEM reflected the subjective impairment better than the
DSI. We conclude that the VEM proved to be a comprehensible and easy-to-use interval-scaled parameter for objective VRP
evaluation in all pathology subgroups. As expected, exclusive consideration of the measured pathology-related influences on the
VEM does not allow conclusions regarding the specific underlying diagnosis.
1. Introduction
Phoniatric voice diagnostics require sophisticated and highly
specialized investigation methods, including objective and
subjective measuring procedures [1–3]. Within this multifac-
torial approach, the recording of a voice range profile (VRP)
under standardized conditions represents an established
objective and noninvasive tool for the examination of vocal
function [4–6]. A stable and straightforward VRP description
succeeds when the vocal extent measure (VEM) is applied [7,
8]. This recently developed innovative parameter describes
the vocal function as a positive one-dimensional measure,
in contrast to the evaluation of dysphonia as a negative crite-
rion by the established multidimensional parameter dyspho-
nia severity index (DSI) [9–11]. The VEM documents the
vocal capacity by quantification of the dynamic and fre-
quency range. It is indicated as interval-scaled value usually
ranging between 0 and 120, whereas these limits may be
exceeded on both sides in severely impaired and exception-
ally great voices. Hence, a large vocal capacity results in a
high VEM value, conversely, a small VRP is characterized
by low VEM. The calculation of this measure is based on
the VRP area and perimeter; the detailed mathematical deri-
vation was presented previously [7, 8, 12]. The VEM is recog-
nized as a user-friendly and easily implementable diagnostic
instrument. The AVA software [13] computes the VEM
automatically after VRP measurement and displays it with-
out additional manual effort or delay.
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So far, only a few investigations have been conducted on
the evaluation of VEM values. Four studies analyzed the
VEM to assess treatment outcomes. Three investigations
dealt with benign organic changes of the vocal folds (VF: 61
polyps [12], 37 nodules [14], and 60 edema [15]), another
one included 152 patients with various laryngeal pathologies
(n = 101) and functional dysphonia (n = 51) [1]. All of these
clinical trials revealed significantly increased VEM values
after phonomicrosurgery or conservative treatment. Besides,
two other studies evaluated reference ranges of the VEM. The
first investigation [8] presented a rough VEM classification
deduced from 564 patients with different types of voice disor-
ders, based on the quartiles of the VEM data (≥106: normal
vocal capacity; <106 to ≥89: mildly reduced; <89 to ≥64:
moderately reduced; <64: severely reduced vocal capacity).
The second study [16] introduced gender-specific VEM
means (M± SD) and reference ranges (RR =M ± 1:96 × SD
) for young and healthy males (124 ± 13; RR: 99-148) and
females (114 ± 13; RR: 88-141). Even though it would sim-
plify the interpretation of vocal complaints in different
pathologies and allow for better evaluation of expectable
treatment success, more precise and comprehensive data
regarding different types of voice disorders as well as healthy
voices are not yet available.
Therefore, the purpose of our study was to gather this
important information by exploring the influences of patho-
logic findings on the VEM, three years after the implementa-
tion of this parameter in voice diagnostics. It was planned to
consider all male and female patients as well as healthy con-
trols in our total study cohort, to examine the effect of spe-
cific underlying pathologies compared to other established
parameters. Our hypotheses were as follows: the VEM (1)
varies between different pathology subgroups, (2) correlates
with the corresponding DSI values, and (3) reflects the
patients’ subjective voice impairment. Furthermore, the
VEM should also be investigated with regard to voice usage,
gender, and age differences. Based on the findings of the liter-
ature, we hypothesized that professional voice use, male gen-
der, and younger age are associated with higher VEM values
[7, 8, 14, 16].
2. Material and Methods
2.1. Participants and Selection Criteria. Three years after the
implementation of the VEM [7], a dataset of 1030 consecu-
tive subjects who visited our phoniatric outpatient clinic
was analyzed in a clinical retrospective study. Within this
36-month acquisition period, the sample consisted of mainly
adult patients with vocal problems, but also of smaller
amounts of children, transgender patients, and healthy par-
ticipants who presented to receive a vocal fitness examination
(control group). All children and transgender subjects were
excluded from further analysis to avoid distortion of results
considering the well-known effects of vocal mutation and
maturation [17, 18] as well as conservative or phonosurgical
gender-transforming procedures [19, 20] on acoustic and
aerodynamic measures. The study was conducted in accor-
dance with the Declaration of Helsinki and approved by the
local ethical review board (reference number: EA4/140/10).
Selection criteria involved informed consent and completion
of the standard phoniatric examination procedures, compris-
ing videolaryngostroboscopy (VLS), acoustic-aerodynamic
voice function diagnostics including VRP measurement,
DSI, and VEM calculation, as well as subjective self-
evaluation using the voice handicap index VHI-9i.
2.2. Pathology-Specific Group Assignment. After taking the
medical history, a digital VLS followed to assess the etiologi-
cal diagnosis of the voice disorder and to evaluate the VF
vibration, esp. glottal closure, regularity, mucosal wave prop-
agation, and symmetry. It was carried out using a high-
resolution rigid videolaryngoscope (10mm; 70°) with inte-
grated microphone connected to the Endo-STROB control
unit (XION Medical, Berlin, Germany). VLS enabled us to
divide the cohort into 2 sample groups: structural and func-
tional dysphonia. The diagnoses were categorized and num-
bered according to the Classification Manual for Voice
Disorders by the American Speech Language and Hearing
Association (ASHA) [21]. We arranged the study subgroups
according to the affected structures and visual pathologies of
the VF. Due to the clinical prevalence and importance of
malignant laryngeal lesions, we decided to investigate them
separately from benign epithelial changes. In these patients,
the specific group assignment was based on the postinterven-
tional histopathological result after microlaryngoscopic exci-
sion. Healthy participants who passed the vocal fitness
examination served as a control group. Finally, the following
pathology subgroups were investigated: group I—malignant
pathologies, group II—lesions of the lamina propria (e.g.,
VF nodules, polyps, cysts, and scars; Reinke’s edema; and sul-
cus vocalis), group III—benign changes of the epithelium,
group IV—inflammatory changes, group V—neurogenic
voice disorders (e.g., unilateral paralyses of the recurrent
laryngeal nerve, vagal nerve, or external branch of the supe-
rior laryngeal nerve; adductor spasmodic dysphonia; and
Parkinson’s disease), group VI—functional disorders, and
group VII—healthy control group.
2.3. Acoustic-Aerodynamic Analysis. Regarding instrument-
assisted objective procedures, the following well-established
methods of measuring were applied: (1) maximum phona-
tion time (MPT) as a statement of aerodynamic capacity
[22, 23], (2) jitter as a common perturbation measure in
acoustic analysis to assess frequency instability [24, 25], and
(3) VRP to display the functional interactions of different
voice production components with regard to vocal frequency
and intensity [26, 27]. Recordings were performed in the
sound-treated (one room) voice lab of our department with
a background noise < 40dB (A), using the DiVAS software
(XION Medical, Berlin, Germany). A head-mounted micro-
phone with a stable mouth-microphone distance of 30 cm
was applied. Relevant instructions of individuals performing
objective acoustic measurements are given in Table 1.
The detailed procedure of VRPmeasurement is described
in a previous publication [7]. The parameters’ highest tone
(F0high), lowest intensity (SPLmin), MPT, and jitter were
used for DSI calculation [9]. The Gonnermann-
classification served for DSI interpretation, discriminating
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healthy voices (≥4.2) from mildly (<4.2 to ≥1.8), moderately
(<1.8 to ≥-1.2), or severely (<-1.2) dysphonic voices [28].
VEM calculation was conducted automatically after VRP
recording by the proprietary AVA software [8, 13].
2.4. Subjective Vocal Impairment and Voice Usage. To take
the subject’s self-assessment into account, every study partic-
ipant had to fill out the VHI-9i questionnaire [29]. This item-
reduced VHI consists of nine questions addressing func-
tional, physical, and emotional impairments, describing the
impact of a voice disorder on a person’s quality of life. Each
question can be rated on a scale from 0 to 4 (0: never; 1:
almost never; 2: sometimes; 3: almost always; 4: always).
The VHI-9i total score ranges from 0 to 36 and allows an
impairment-related severity classification (0-5: no dyspho-
nia; 6-13: mild dysphonia; 14-22: moderate dysphonia; 23-
36: severe dysphonia) as proposed by Seipelt and Nawka
[30]. Furthermore, the questionnaire registers the subject’s
profession as well as the individual use of speaking and sing-
ing voice. Simplifying the vocal use classification system by
Koufman and Isaacson [31], the cohort was divided into
“professional voice users” (PVU) and “non-professional
voice users” (nPVU) depending on the reported occupation
and voice usage.
2.5. Statistical Analysis. All data were statistically analyzed
using SPSS version 25 (IBM Corp., Armonk, N.Y., USA).
Descriptive statistics were applied to evaluate the basic quan-
titative features of the data collected. We documented the
minimum and maximum values, calculated medians, first
and third quartiles, and means and standard deviations
(SD) for all objective and subjective parameters as well as
patients’ sociodemographic data. By using the one-way anal-
ysis of variance (ANOVA) with post hoc analysis, we exam-
ined the differences of mean values and their significance
considering pathology subgroups, gender, and voice usage.
Scatterplots with regression lines were made for females
and males to display the dependence of VEM and other
objective parameters on VHI-9i. Boxplots were chosen as
graphical technique to present pathology-related VEM and
DSI ranges. Pearson’s correlation coefficients were computed
to investigate the strength and direction of association
between the individual parameters in all study participants
and in each pathology subgroup. The level of significance
was set at α = :05. The following abbreviations were used to
show different significance levels: ∗ = 5%; ∗∗ = 1%; ∗∗∗ = 0:1
%.
3. Results
3.1. Description of the Study Cohort. The complete dataset
comprised 994 study participants, 376 male (18-86 years,
median 57) and 618 female subjects (18-82 years, median
47). Women were on average 9 years younger than men at
the time of consultation (46 ± 17 vs. 55 ± 16, mean ± SD,
and p < 0:05). The age and gender distribution of the exam-
ined cohort is shown in Figure 1.
VLS revealed in 691 subject (69.5%) organic diseases at
VF level. Classification of the resulting structural dysphonia
according to the underlying pathology showed in 26.5% dis-
eases of the lamina propria (e.g., nodules, polyps, cysts, and
edema), in 15.9% neurogenic voice disorders (e.g., VF paral-
ysis and spasmodic dysphonia), in 14.7% diseases of the epi-
thelium (e.g., leukoplakia, hyperkeratosis, carcinoma, and
papillomatosis), and in 12.4% inflammatory findings (e.g.,
laryngitis). Additionally, VLS did not show any organic
changes in 303 study participants (30.5%). From those indi-
viduals with normal laryngeal anatomy, 22.5% suffered from
a vocal load-induced functional dysphonia, while 8.0% were
completely healthy without any voice complaints (control
group). Comparing our pathology subgroups, most voice dis-
orders occurred in the 5th decade of life, except lamina pro-
pria changes (4th decade) and malignant lesions (5th to 6th
Table 1: Instruction of individuals performing objective acoustic measurements.
Measure Phonatory tasks
Jitter
Standing position. Produce a sustained vowel (/na/or/a/) for 3-5 seconds. Use a comfortable pitch and loudness.
The most stable recording out of 3 trials was chosen for DSI calculation.
MPT
Standing position. Produce a sustained vowel (/a/or/na/) for as long as possible after maximum inhalation. Use a comfortable
pitch and loudness.
The longest phonation time out of 3 trials was chosen for DSI calculation.
VRP
Standing position. Initial assessment of speaking VRP, followed by singing VRP.
(1) Speaking voice. Count from 21 to 25 at different intensity levels
1a: Lowest volume possible (unstressed phonation at indifferent pitch)
1b: Normal conversation volume (fist level of increase)
1c: Speaker’s voice (lecture hall volume, second level of increase)
1d: Loudest volume possible (calling voice)
(2) Singing voice. Produce a sustained vowel (/na/or/a/) for at least 2 seconds at different intensity levels
2a: As softly as possible
2b: As loud as possible
For both settings, begin at a comfortable middle pitch. Stepwise reduce the pitch to the lowest possible note. Return to comfortable
pitch and get stepwise higher in pitch as far as possible.
The perimeter and area between the curves of soft and loud singing VRP served for VEM calculation.
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decade). A detailed description of the investigated parame-
ters in our study population is presented in Table 2.
3.2. Effects of Gender, Voice Use, and Age. In both genders,
the overall vocal, aerodynamic, and psychometric parameters
indicated mild to moderate impairments. Males and females
had mildly dysphonic voices with slightly reduced vocal
capacities. According to the mean VHI-9i scores (16 ± 8 vs.
15 ± 9), the self-assessed vocal impairment was comparable.
Females revealed higher mean values for F0high and DSI, as
well as lower values for SPLmin, jitter, and VHI-9i. Males
reached higher values for MPT and VEM. These gender-
specific differences were statistically significant for the
parameters F0high, SPLmin, MPT, DSI (all p < 0:001), and
jitter (p < 0:05), but not significant for VEM and VHI-9i.
Regarding voice usage, this cohort consisted of 3 groups:
29% PVU (n = 286, e.g., teachers, preschool teachers, lec-
turers, instructors, salespersons, singers, and actors), 59%
nPVU (n = 585, e.g., administration employees, laborers,
business (wo)men, pensioners, and unemployed people),
and 12% with missing answers concerning occupation
(n = 123). When consulting a voice specialist in our depart-
ment, PVU were on average 8 years younger than nPVU
(44 ± 14 vs. 52 ± 18 years, p < 0:001). The voice use had a sig-
nificant influence on the objective parameters: compared to
nPVU, PVU generally reached higher mean values for
F0high, MPT, DSI, and VEM (all p < 0:001), as well as the
lowest mean values for SPLmin (p < 0:001) and jitter
(p < 0:05). However, comparison of the VHI-9i scores
revealed that the subjective impairment did not differ signif-
icantly between PVU and nPVU.
Focusing on VHI-9i results, 22.4% of all subjects felt
highly (score 23-36), 33.2% moderately (score 14-22), and
30.5% mildly affected (score 6-13), while 13.9% of the partic-
ipants did not indicate relevant voice impairment (score 0-5).
However, subjective complaints rose with age. According to
the severity classification, the mean age continuously
increased as follows: 44 ± 19 (no dysphonia) vs. 46 ± 18 (mild
dysphonia) vs. 52 ± 17 (moderate dysphonia) vs. 54 ± 14
years (severe dysphonia). These age-dependent VHI deterio-
rations were significant in women (p < 0:001) and showed a
trend in men (p = 0:069). In accordance with rising subjective
impairment levels, the objective parameters gradually wors-
ened as well (i.e., constant decline of F0high, MPT, DSI,
and VEM vs. increase of SPLmin and jitter). In both genders,
these changes were highly significant (p < 0:001), apart from
men’s SPLmin (p < 0:05) and jitter (p = 0:075). Exemplarily,
Figure 2 visualizes the scatterplots for the parameters MPT,
DSI, and VEM on the y-axis related to VHI-9i on the x-axis.
3.3. Correlation Analysis and VEM Grading System. Correla-
tion analysis showed that VEM correlated significantly
(p < 0:01) with F0high (r = 0:48∗∗), SPLmin (r = −0:46∗∗),
MPT (r = 0:44∗∗), jitter (vs. r = −0:15∗∗), and DSI
(r = 0:63∗∗). DSI and VEM correlated furthermore with
VHI-9i (r = −0:36∗∗ vs. r = −0:42∗∗). The strength of these
relationships was moderate, apart from the weak negative
relationship between VEM and jitter. Regarding age, correla-
tions showed significant (p < 0:01) moderate relationships
with F0high (r = −0:45∗∗), SPLmin (r = 0:32∗∗), and DSI
(r = −0:44∗∗), compared to weak relationships with jitter
(r = 0:12∗∗), VEM (r = −0:27∗∗), and VHI-9i (r = 0:21∗∗).
Finally, derived from the VEM percentiles of the total
cohort (25%: 69; 50%: 93; 75%: 108), we created a grading
system to compare the means of the investigated parameters
on different VEM levels (Table 3). As a result, the higher the
VEM, the higher the mean values for F0high, MPT, and DSI,
and the lower the mean values for SPLmin, jitter, and VHI-9i.
The VEM also seems to decrease as the voice ages. Regardless
of the underlying pathology, subgroups I-VI comprised every
VEM level. The mean values of all vocal parameters differed
significantly between the VEM levels (p < 0:001).
3.4. Effects of Pathology in all Subgroups. Subgroup I con-
tained patients with carcinoma in situ (n = 8), pT1a (n = 55
), and pT1b (n = 12) squamous cell carcinoma. Males were
significantly more often affected than females (average ratio
6.5: 1). At initial diagnosis, women were on average 12 years
younger than men (p < 0:05). The aerodynamic and acoustic
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Figure 1: Histograms of age by gender in the total cohort.
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voices in both genders. Compared to men, women had “bet-
ter”mean values for all objective parameters apart fromMPT
and VEM. In contrast to that, their subjective suffering was
higher (21 ± 6 vs. 17 ± 8), but not on a significant level
(p = 0:165). In comparison with other pathology subgroups,
mean values were the worst for F0high, SPLmin, jitter, DSI,
and VEM.
Subgroup II involved the following pathologies: VF nod-
ules (n = 91), Reinke’s edema (n = 76), VF polyps (n = 33),
sulcus vocalis (n = 22), VF cysts (n = 18), VF scars (n = 11),
vascular malformation (n = 5), bamboo nodes (n = 4), and
VF hematoma (n = 3). Females were significantly more often
affected than males (average ratio 3.3: 1), especially concern-
ing Reinke’s edema (11.7: 1) and VF nodules (7.3: 1). Apart
from the latter diagnoses, we found no relevant gender-
specific differences for age, size, or location of findings at ini-
tial consultation. Women showed significantly higher values
for F0high (p < 0:001) and lower values for MPT (p < 0:001)
as well as VEM (p < 0:05). Gender-independent comparison
between nodules, polyps, and Reinke’s edema regarding
mean VEM (101 ± 23 vs. 84 ± 24 vs. 72 ± 29) and DSI
(4:4 ± 2:0 vs. 2:5 ± 1:7 vs. 2:0 ± 2:0) revealed highly signifi-
cant differences (p < 0:001).
Subgroup III included patients with laryngeal papilloma-
tosis (n = 38), leukoplakia (n = 20), and VF granuloma
(n = 14). Men were more often affected than women (average
ratio 1.6: 1) and on average 9 years older at first presentation
(p < 0:05). Apart from the known differences regarding
Table 2: Characteristics of vocal parameters considering gender, age, and pathology subgroups. The number (n) and percentage (%) of
participants, as well as the mean values and standard deviations (mean ± SD) for age (in years), highest frequency (F0high in hertz), lowest
intensity (SPLmin in decibel), maximum phonation time (MPT in seconds), jitter (in %), dysphonia severity index (DSI), vocal extent
measure (VEM), and voice handicap index (VHI-9i) are displayed.
Cohort I-VII Subgroup I Subgroup II Subgroup III Subgroup IV Subgroup V Subgroup VI Subgroup VII
Participants (number, %) 994 (100%) 75 (7.5%) 263 (26.5%) 72 (7.2%) 123 (12.4%) 158 (15.9%) 224 (22.5%) 79 (8.0%)
Male 376 (37.8%) 65 (86.7%) 61 (23.2%) 44 (61.1%) 54 (43.9%) 59 (37.3%) 81 (36.2%) 12 (15.2%)
Female 618 (62.2%) 10 (13.3%) 202 (76.8%) 28 (38.9%) 69 (56.1%) 99 (62.7%) 143 (63.8%) 67 (84.8%)
Age (years, mean ± SD) 49 ± 17 62 ± 13 44 ± 15 54 ± 15 53 ± 14 56 ± 14 52 ± 18 25 ± 9
Male 55 ± 16 64 ± 12 45 ± 15 58 ± 14 53 ± 15 57 ± 13 57 ± 18 23 ± 4
Female 46 ± 17 52 ± 14 43 ± 14 49 ± 16 52 ± 14 55 ± 14 50 ± 17 25 ± 9
F0high (Hz, mean ± SD) 470 ± 188 324 ± 112 463 ± 180 388 ± 130 458 ± 198 413 ± 138 518 ± 176 709 ± 173
Male 355 ± 116 309 ± 99 372 ± 134 325 ± 104 382 ± 130 318 ± 90 384 ± 97 507 ± 110
Female 540 ± 190 419 ± 144 490 ± 182 488 ± 102 517 ± 220 470 ± 130 594 ± 165 742 ± 158
SPLmin (dB,mean ± SD) 50 ± 5 53 ± 5 49 ± 4 51 ± 5 51 ± 5 51 ± 5 49 ± 5 47 ± 3
Male 51 ± 5 53 ± 5 50 ± 5 51 ± 5 52 ± 5 51 ± 5 50 ± 6 47 ± 3
Female 49 ± 4 51 ± 5 49 ± 4 51 ± 5 51 ± 5 50 ± 4 49 ± 4 47 ± 3
MPT (s, mean ± SD) 12 ± 6 11 ± 5 12 ± 6 13 ± 6 13 ± 6 9 ± 5 14 ± 5 16 ± 5
Male 13 ± 7 11 ± 5 14 ± 7 14 ± 6 14 ± 6 10 ± 7 15 ± 6 20 ± 7
Female 12 ± 5 10 ± 5 11 ± 5 10 ± 4 12 ± 5 9 ± 4 13 ± 5 15 ± 4
Jitter (%, mean ± SD) 0:3 ± 0:8 0:7 ± 1:2 0:3 ± 0:7 0:3 ± 0:5 0:2 ± 0:1 0:6 ± 1:1 0:3 ± 0:8 0:1 ± 0:1
Male 0:4 ± 0:9 0:7 ± 1:3 0:3 ± 0:4 0:3 ± 0:6 0:2 ± 0:1 0:6 ± 1:1 0:4 ± 0:9 0:2 ± 0:1
Female 0:3 ± 0:7 0:3 ± 0:6 0:3 ± 0:8 0:2 ± 0:1 0:2 ± 0:1 0:5 ± 1:1 0:3 ± 0:8 0:1 ± 0:1
DSI (mean ± SD) 3:1 ± 2:4 1:1 ± 2:3 3:2 ± 2:2 2:6 ± 1:9 3:0 ± 2:2 2:0 ± 2:2 3:8 ± 2:2 5:9 ± 1:4
Male 2:4 ± 2:3 0:8 ± 2:2 3:0 ± 1:8 2:4 ± 2:2 2:7 ± 2:1 1:5 ± 2:2 3:1 ± 2:0 5:4 ± 1:6
Female 3:6 ± 2:4 2:6 ± 2:5 3:3 ± 2:3 2:9 ± 1:4 3:2 ± 2:3 2:3 ± 2:1 4:2 ± 2:2 6:0 ± 1:3
VEM (mean ± SD) 86 ± 31 60 ± 31 88 ± 28 81 ± 30 93 ± 30 70 ± 31 95 ± 25 109 ± 18
Male 88 ± 33 61 ± 30 96 ± 28 86 ± 32 102 ± 27 76 ± 32 99 ± 28 121 ± 13
Female 85 ± 30 50 ± 39 86 ± 28 75 ± 26 87 ± 30 67 ± 30 92 ± 24 106 ± 18
VHI-9i (mean ± SD) 15 ± 9 18 ± 8 15 ± 8 15 ± 9 14 ± 8 21 ± 9 14 ± 8 6 ± 5
Male 16 ± 8 17 ± 8 15 ± 8 15 ± 9 14 ± 7 20 ± 9 15 ± 8 4 ± 1
Female 15 ± 9 21 ± 6 15 ± 8 14 ± 9 14 ± 9 22 ± 8 14 ± 8 7 ± 6
Subgroup I—malignant pathologies, subgroup II—lesions of the lamina propria, subgroup III—benign changes of the epithelium, subgroup IV—inflammatory
changes, subgroup V—neurogenic voice disorders, subgroup VI—functional disorders, and subgroup VII—healthy control group.
5BioMed Research International
F0high (p < 0:001) and MPT (p < 0:05), both genders
revealed similar results for SPLmin, jitter, and VHI-9i. How-
ever, higher values for VEM in males and DSI in females did
not reach the level of significance.
Subgroup IV patients had acute (n = 26) or chronic lar-
yngitis (n = 97). Females and males were nearly equally
affected (average ratio 1.3: 1) and showed comparable means
in age, SPLmin, jitter, and VHI-9i. Gender-specific differ-
ences were significant for F0high (p < 0:001), MPT, and
VEM (p < 0:05), but not for DSI (p = 0:191).
Subgroup V involved the following heterogeneous
pathologies: unilateral paralyses of the recurrent laryngeal
nerve (n = 124), vagal nerve (n = 8), or external branch of
the superior laryngeal nerve (n = 4), adductor spasmodic
dysphonia (n = 19), Parkinson’s disease (n = 2), and amyo-
trophic lateral sclerosis (n = 1). Females were more often
affected than males (average ratio 1.7: 1). Both genders
matched in age and presented with substantially impaired
vocal parameters. SPLmin, MPT, jitter, and VHI-9i did not
expose relevant gender-specific differences. Higher mean
values reached the level of significance in women for F0high
(p < 0:001) and DSI (p < 0:05), but not in men for VEM
(p = 0:101). In comparison with other pathology subgroups,
mean values were the worst for MPT and VHI-9i.
Subgroup VI included patients with dysodia (n = 119),
hypo-/hyperfunctional dysphonia (n = 65), and presbypho-
nia (n = 34), as well as paradoxical VF movement disorder
(n = 6). Females were more often affected than males (aver-
age ratio 1.8: 1) and on average 7 years younger when con-
sulting the voice specialist (p < 0:05). Despite moderately
impaired VHI-9i scores, both genders reached the highest
values of all dysphonic patients for F0high, MPT, DSI, and
VEM. Significant gender-specific differences were not
detected, apart from F0high and DSI (p < 0:001). Gender-
independent comparison between presbyphonic, dysodic,
and hyperfunctional patients regarding mean VEM (78 ± 29
vs. 97 ± 24 vs. 107 ± 17) and DSI (2:0 ± 2:0 vs. 4:0 ± 2:2 vs.
5:5 ± 1:4) exposed highly significant differences (p < 0:001).
Subgroup VII consisted of considerably more women
than men (average ratio 5.6: 1). All subjects showed normal
laryngeal findings in the VLS and passed the vocal fitness















































































Figure 2: Scatterplots and regression lines of objective vocal parameters MPT, DSI, and VEM in relation to subjective impairment-related
VHI-9i scores separated for males and females.
Table 3: Effects of VEM levels on the investigated parameters (mean ± SD).
VEM level Participants n (%) Age (years) F0high (Hz) SPLmin (dB) MPT (s) Jitter (%) DSI VEM VHI
0 243 (24.4%) 40 ± 17 606 ± 203 47 ± 3 15 ± 5 0:2 ± 0:2 5:2 ± 1:7 120 ± 9 11 ± 7
1 241 (24.2%) 49 ± 18 501 ± 170 49 ± 4 14 ± 5 0:3 ± 0:9 3:7 ± 2:0 101 ± 4 14 ± 7
2 252 (25.4%) 52 ± 17 431 ± 148 50 ± 4 11 ± 5 0:3 ± 0:7 2:8 ± 1:6 82 ± 7 16 ± 9
3 258 (26.0%) 55 ± 14 352 ± 127 53 ± 5 9 ± 5 0:5 ± 1:1 1:0 ± 2:1 44 ± 20 21 ± 7
The grading of VEM levels was based on the percentiles of the total study cohort (n = 994). Level 0: normal vocal capacity (VEM ≥ 108) ≙ 100th percentile (Q4).
Level 1: mildly reduced vocal capacity (VEM< 108 to ≥93) ≙ 75th percentile (Q3). Level 2: moderately reduced vocal capacity (VEM< 93 to ≥69) ≙ 50th
percentile (Q2). Level 3: severely reduced vocal capacity (VEM< 69) ≙ 25th percentile (Q1).
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genders presented at a much younger age and reached the
best values in all observed vocal parameters (p < 0:001).
Within this group, gender-specific differences showed signif-
icantly higher means for MPT, jitter, and VEM in men (all
p < 0:05), as well as for F0high in women (p < 0:001).
Comparison of all subgroups demonstrated that means
for all vocal parameters differed significantly between them
(p < 0:001). The post hoc analysis revealed that controls with
a healthy voice were reliably distinguished from patients with
an impaired voice in all examined parameters. Exemplarily,
pathology-specific ranges for VEM and DSI are shown in
Figure 3.
4. Discussion
In this study, we examined the pathology-induced changes of
different voice disorders on the acoustic and aerodynamic
parameters of the VRP with focus on the new VEM. Our
results showed novel VEM outcomes concerning (1) varia-
tion between different pathology subgroups, (2) correlation
with corresponding DSI values, (3) reflection of subjective
voice impairment, and (4) changes with regard to voice
usage, gender, and age differences. However, the heterogene-
ity of results regarding how pathology affected the investi-
gated vocal measures and their relations must be critically
discussed. From a clinical viewpoint, it is still not enough
known about how these differences are explicable by vocal
training, age, or gender and how to separate these factors
from pathology.
4.1. Effects of Gender, Voice Use, and Age. The VEM exceeded
the common range of 0 to 120 at both ends without showing
any gender-specific differences (males: -12 to 152 [mean 88]
vs. females: -13 to 147 [mean 85]). It correlated significantly
with the DSI and corresponded to the same moderate subjec-
tive impairment level in men and women. The VEM showed
a higher correlation with the VHI-9i total score than the DSI.
Therefore, the VEM reflected the subjective perception bet-
ter. Former studies stated that DSI and VHI are complement-
ing parameters since there was no significant correlation
detected [32, 33]. We conclude that VEM, DSI, and VHI rep-
resent complementing but different dimensions in voice
diagnostics.
In contrast to VEM, a significant gender difference was
found in F0high, SPLmin, MPT, and DSI. Females kept their
physiologically higher F0high in all pathologies and in the
healthy vocal state, resulting in a higher DSI (even when feel-
ing more impaired). Other investigations confirmed a signif-
icantly higher F0high in females and the tendency for higher
MPT in males, but could not detect a significant gender dif-
ference for DSI in subjects without voice complaints [34,
35]. Another study indicated that the DSI is influenced by
the registration program as well as gender in patients with
voice disorders [7]. The present investigation confirms these
findings partially. When comparing the total cohort by gen-
der, there was a significant difference found in DSI values,
but in subgroup analysis, only patients with neurogenic
lesions (V) and functional disorders (VI) differed on a signif-
icant level. Interestingly, those two groups are the ones where
both genders showed no significant difference in MPT mea-
sures. Therefore, the influence of MPT as a considerable
compensation mechanism in multidimensional DSI calcula-
tion must be further discussed.
Regarding VEM differences between PVU and nPVU,
Caffier et al. [14] showed in patients with VF nodules a signif-





















































Figure 3: Comparison of (a) VEM and (b) DSI in each pathology subgroup. Median, quartiles, and range of values covered by the data, and
any outliers (single spots) are presented using boxplots.
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VHI-9i impairment levels. Our study confirmed these results.
Even among healthy subjects, a small proportion rated their
voices mildly to moderately impaired according to the
VHI-9i. All of them were female and prospective or active
PVU. One explanation could be that PVU have particularly
high demands and expectations regarding their vocal quality
and performance. They depend on a proper function of their
voices to “perform” at its best in their profession. When
entering a vocal fitness examination, especially females tend
to assess their voices overcritically, even when VRP measure-
ments display a healthy or exceptional great voice. This is in
line with the results of Chitguppi et al., which showed that
female PVU with no obvious VF pathology reported signifi-
cantly more voice-related complaints than nPVU, while
reaching in all investigated objective vocal parameter values
above average [36].
As expected, younger age was associated with higher
VEM values. Similar to former studies, the age distribution
revealed the majority of our patients in the working pop-
ulation, where the voice is most needed [37–39]. The age
difference of 8 years implies that PVU consult a physician
at an earlier stage, but we did not measure the exact
pathology sizes in the VLS to prove this assumption. The
VEM was highest in young healthy subjects. The VEM
quartiles showed a decrease of VEM with rising age. How-
ever, lifelong laryngeal training can postpone signs of
vocal aging [40, 41]. Regardless of age, the presented
values of VEM quartiles (Q1: VEM < 69; Q2: VEM ≥ 69
to <93; Q3: VEM ≥ 93 to <108; Q4: VEM ≥ 108) could
serve in the future as a reference range for the classifica-
tion of vocal capacity in dysphonic patients and healthy
subjects.
4.2. Effects of Pathology in all Subgroups. The VEM in all
pathology subgroups differed significantly, without resulting
in specific values or ranges that could (pre)determine the
medical diagnoses. Every pathology influenced the intensity
and frequency range on a distinct level, so that the VEM var-
ied in one pathology from slightly to highly reduced. As
known, the VRP aids to present the patients phonatory status
without predicting the diagnosis [42]. Other studies con-
firmed that the VRP contour and its parameters are influ-
enced by an organic voice disorder without showing a
pathology-specific VRP configuration [43, 44].
Similar to previous studies, healthy subjects (VII)
reached the highest VEM and DSI values while assessing
their voices being not impaired [7, 16]. They could be clearly
separated from patients with voice disorders by VEM and all
other examined parameters. Subjects diagnosed with func-
tional voice disorders (VI) had the best VEM and DSI values
of the dysphonic patients and assessed their voices as moder-
ately impaired. Dysfunction without organic changes is
accompanied by impaired aerodynamic and acoustic mea-
sures [45–47]. Within the heterogenic group of functional
dysphonia, we found significant VEM differences between
presbyphonic, dysodic, and hyperfunctional patients, pro-
posing that the term “non-organic/functional” voice disorder
is widely composed and needs clarification in nomenclature
settings.
Patients with malignant epithelial lesions (I) had the low-
est VEM and can be clearly separated from other subgroups.
The VEM also differed significantly from benign changes of
the epithelium (III). Likewise, Kang et al. [43] detected a
lower objective voice quality (jitter, shimmer, and noise-to-
harmonic ratio) as well as a higher subjective impairment
(VHI) in patients with glottic carcinoma compared to benign
epithelial lesions. The change of the microarchitecture of the
epithelial layer leads to an irregular rough surface and voice
abnormalities due to increased mass, interference with vibra-
tory behavior, and compromised VF closure. Confirming the
literature, increasing thickening and infiltration resulted in a
reduced or absent mucosal wave with growing stiffness of the
lesion; the glottal closure could be also progressively
impaired [48–50].
Patients with neurogenic voice disorders (V) assessed
their voices higher impaired than the carcinoma group (I),
but showed better functional measurements (except for
MPT). This heterogeneous subgroup involved absent,
decreased, or increased VF motions due to neurological or
muscular disorders causing glottal insufficiency or dystonic
spasms in varying degrees. As known from other studies,
patients with unilateral VF paralysis reported vocal fatigue,
dys-/aphonia and a breathy voice due to air escape; the extent
depends on the position of the paralyzed VF [51, 52]. Omori
et al. [53] found the glottal gap size as the main factor for
reduced voice quality rather than the underlying diagnosis.
Therefore, the comparable VEM in neurogenic and malig-
nant lesions can be partly explained by the amount of glottal
insufficiency, depending on the extent of infiltration, respec-
tively, paralysis.
Benign changes of the lamina propria (II), the epithelium
(III), and inflammatory lesions (IV) led to comparable mod-
erately impaired VEM, DSI, and VHI-9i values. As expected,
all included pathologies interfered with the vibratory behav-
ior and closure pattern and resulted in roughness and/or
breathiness. Confirming previous studies, more diffuse
lesions with an excess of liquid, gelatinous, or fibrous mate-
rial raised the VF stiffness and increased (e.g., Reinke’s
edema) or decreased (e.g., laryngitis and sulcus vocalis) the
mucosal wave [21, 54]. On the other hand, the VEM was able
to differentiate between VF nodules, polyps, and Reinke’s
edema by showing a different vocal capacity related to the
pathology dimensions.
4.3. Limitations. This study involves a few limitations, which
should be considered when drawing general conclusions.
Firstly, auditory perceptual assessment was unfortunately
not included in the initial study design. Due to the large
amount of data, a retrospective blinded voice evaluation of
994 patients with 4-5 raters was not an available option. Sec-
ondly, the exact extent of the leading pathology was not clas-
sified or measured. However, the importance of the size of
the findings should not be underestimated. For example, Sal-
men et al. found in patients with varying sizes of Reinke’s
edema significant differences in VEM and DSI values
depending on the Yonekawa classification [15]. Thirdly, var-
ious subgroups (e.g., II and VI) were very heterogeneous in
itself, creating the false impression that the vocal capacity,
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respectively, impairments of different pathologies included
are alike. Fourthly, the effects of age on the VEM can only
be estimated since our patients above 45 years were all classi-
fied with a voice disorder. Considering the close relationship
to the DSI and its proven influence on age [34, 35, 55], an age
effect is likely. As there is no reliable differentiation between
the effects of age and pathology, further investigations should
include a larger age variety of healthy subjects. Besides, the
VEM can only be calculated on the basis of a completed
VRP. However, due to the parameter construction, an apho-
nic voice cannot be quantified by the VEM. In addition, fur-
ther studies are necessary relating the presented VEM
quartiles (Q1: VEM < 69; Q2: VEM ≥ 69 to <93; Q3: VEM
≥ 93 to <108; Q4: VEM ≥ 108) to the auditory perceptual
assessment of voices.
5. Conclusions
We conclude that the VEM proved to be a comprehensible
and easy-to-use interval-scaled parameter for objective VRP
evaluation in all laryngeal pathologies. By quantifying the
vocal capacity, it represents vocal function as a positive mea-
sure and should therefore be established as a useful and com-
plementary parameter in addition to the DSI. Besides, the
VEM seems to reflect the subjective impairment better than
the traditional DSI. However, the size of the VEM value alone
does not allow to draw conclusions about the underlying
diagnosis.
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